APOC3 and systemic lupus erythematosus: As atherosclerosis in SLE patients is not solely depending on traditional risk factors [68,69], the authors suggest that the increase in the pro-atherogenic apoCIII could be a contributing factor to the renal complication and might be used as a biomarker for the risk of developing nephritis and atherosclerosis [65].